NEW REACTOR FOR DRUG DISCOVERY LIBRARIES

Information

  • Research Project
  • 2536698
  • ApplicationId
    2536698
  • Core Project Number
    R44GM054501
  • Full Project Number
    2R44GM054501-02
  • Serial Number
    54501
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/1996 - 28 years ago
  • Project End Date
    8/31/1999 - 24 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/1997 - 26 years ago
  • Budget End Date
    8/31/1998 - 25 years ago
  • Fiscal Year
    1997
  • Support Year
    2
  • Suffix
  • Award Notice Date
    9/22/1997 - 26 years ago
Organizations

NEW REACTOR FOR DRUG DISCOVERY LIBRARIES

DESCRIPTION: The proposed Phase I project is aimed at developing a new process for generating mixtures of compounds with unique structures. As envisioned, these mixtures of novel compounds (termed "chemical libraries") will have attributes appropriate for subjecting them to high-throughput screening of bioactivity for the purpose of discovering new pharmaceuticals. The process promises to be a convenient, economical method for producing many structurally diverse compounds. In Phase I the investigators propose to show that the new process can 1) produce mixtures of unique compounds from a range of starting materials; 2) be controlled so that the majority of compounds in this mixture have chemical and physical properties that match those of most pharmaceuticals: 3) yield mixtures suitable for use in high-throughput screening; and 4) operate reproducibly, allowing generation of substantial quantities of molecules identified during screening as active (to allow structure elucidation). In Phase II the process will generate chemical libraries with diverse chemical compositions. A major pharmaceutical company will collaborate with the investigators - subjecting the chemical libraries to screening of bioactivity for a broad range of therapeutic uses. Compounds shown to be bioactive will be structurally identified. Analogs of active compounds will be prepared and likewise screened for bioactivity.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG3
  • Study Section Name
  • Organization Name
    BEND RESEARCH, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    BEND
  • Organization State
    OR
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    977018583
  • Organization District
    UNITED STATES